Karyopharm Therapeutics Inc. (KPTI)

NMS – Real Time Price. Currency in USD

8.92

+0.01 (0.06%)

Market open: May 13, 2026, 9:43 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

146M

145M

146M

157M

Cost of goods sold

-6M

-5M

-6M

Gross Profit

140M

139M

141M

151M

Operating expenses (excl. COGS)

-231M

-258M

-270M

-293M

Operating Income

-91M

-119M

-130M

-142M

Non-operating income, total

-105M

43M

-13M

-23M

Pretax income

-196M

-76M

-143M

-165M

Equity in earnings

Taxes

-43K

-57K

-323K

-369K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-196M

-76M

-143M

-165M

Karyopharm Therapeutics Inc. (KPTI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Karyopharm Therapeutics Inc. (KPTI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Karyopharm Therapeutics Inc. (KPTI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Karyopharm Therapeutics Inc. (KPTI)

Income Statement (Annual)

Income Statement (Annual)